Ambrisentan for the treatment of pulmonary arterial hypertension: improving outcomes
Soha M Elshaboury,1 Joe R Anderson21College of Pharmacy, University of New Mexico, 2Pharmacy Practice and Internal Medicine, College of Pharmacy and School of Medicine, University of New Mexico, Albuquerque, NM, USAAbstract: Pulmonary arterial hypertension (PAH) is a progressive disease of the pulmo...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2013-05-01
|
| Series: | Patient Preference and Adherence |
| Online Access: | http://www.dovepress.com/ambrisentan-for-the-treatment-of-pulmonary-arterial-hypertension-impro-a12989 |